News & Analysis as of

HRSA Final Rules Medicaid

Alston & Bird

Health Care Week in Review: CMS Releases PFS, OPPS, ESRD, and Home Health Final Rules; Senators Cassidy and Hassan Release a...

Alston & Bird on

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

McGuireWoods Consulting

Washington Healthcare Update - January 2023

This Week in Washington: 118th Congress begins, House finally chooses Speaker...more

McGuireWoods Consulting

Washington Healthcare Update - June 2022

This Week in Washington: House Passes FDA User Fee Reauthorization Package...more

McGuireWoods Consulting

Washington Healthcare Update - April 2022 #3

This Week in Washington: White House Releases National Drug Control Strategy...more

Holland & Knight LLP

CMS Finalizes Policies on Residency Positions and Organ Procurement Payment

Holland & Knight LLP on

The Centers for Medicare & Medicaid Services (CMS) has released the Final Rule with a comment period for the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals; Changes to Medicare Graduate Medical...more

Foley & Lardner LLP

Organ Procurement Organization Final Rule Takes Effect

Foley & Lardner LLP on

After some implementation delays, the final rule updating Organ Procurement Organization (OPO) performance measures took effect April 1, 2021. The final rule, titled, “Medicare and Medicaid Programs: Organ Procurement...more

Mintz - Health Care Viewpoints

CMS Notifies States of AMP Rule Requirements: 340B Providers Should Take Note

Last week, Mintz Levin and ML Strategies released a joint Alert analyzing key provisions of the Covered Outpatient Drug final rule (“Final AMP Rule”) and their impact on manufacturers, pharmacy benefit managers (“PBMs”), and...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide